Etubics Corporation products are under development. They consist of biopharmaceuticals (vector vaccines) that will be used to immunize individuals against infectious agents causing difficult-to-treat diseases such as bioterrorism targets, malaria, human immunodeficiency virus, Leishmania, influenza and other acute or chronic diseases. The Company is also developing products to treat certain cancers. The products will be delivered to the market through existing pipelines.

Patents issued; patent cooperation treaty documents filed and current